Sponsored • Schiller
Explore the new world of ECGs
Come and visit us at booth A300 at the ESC in London. SCHILLER is delighted to present you its latest innovations!
Cardiovascular diseases
News • Genetics
Blood pressure regulation by a stress-sensitive gatekeeper
Researchers at the RIKEN Brain Science Institute have uncovered a new mechanism for the regulation of blood pressure. Published in Molecular Cell, the study links events at the single-cell level to a system-level effect, showing that blood pressure can drop dramatically if the protein ERAP1 is released from cells and enters the blood stream.
News • Arterial thrombosis
Cloaking of collagen frees up the flow
Blood clots often form when lipid-rich plaques on the inner surface of arteries rupture and platelets aggregate at the site of injury. LMU cardiologists have now compared the effects of two new platelet aggregation inhibitors.
Article • Cardiology I
Chest pain units in Germany
The German care system for patients with acute and unspecific chest pain is unique in Europe. The closely knit and countrywide network of accredited Chest Pain Units (CPUs) ensures fast and targeted diagnosis of acute cardiac events. The German CPUs may soon serve as a blueprint for other European countries. The German Cardiac Society (DGK) has already accredited the first institutions – others…
News • Stroke
Effectiveness of treatment confirmed
A research paper published in the New England Journal of Medicine (NEJM) today confirms earlier findings that a procedure called endovascular therapy (ET) for ischemic stroke is the best treatment option for many patients by reducing the incidents of disability. This is the fourth research paper published this year that confirms the efficacy of the treatment.
Article • Education
Cardiologists gain MRI training
Seeing a substantially increasing importance of the cardiac MRI procedure, cardiologists have developed a specialist cardiac MRI training programme for their colleagues.
Sponsored • R/F Digital
Shimadzu - Deep insights for extended applications
In the year of Shimadzu’s 140th anniversary, new systems continue the company’s tradition in diagnostic imaging providing innovative technologies and industry firsts.
News • CARDIS
New European effort targeting mobile cardio vascular disease
Imec, Medtronic, Ghent University and their project partners today announced the launch of the CARDIS project. Together they will develop and validate an early-stage cardio vascular disease detection platform using integrated silicon photonics.
Stepping towards CD disease prevention
Cardiovascular disease develops in a slow and subclinical manner over decades, only to manifest suddenly and unexpectedly. Prevention is crucial, both before and after clinical appearance, Report: Dr Eduardo de la Sota
Article • Cardiac MRI
Cardiomyopathy: the chameleon disease
Cardiomyopathy is a disease with many faces, a 'chameleon', according to Professor Jeanette Schulz-Menger. MRI benefits and potential should be communicated better and to a wider clinical audience. Report: Axel Viola
CARDIOVIT MS-Line now with CCAA
In the year of its 40th anniversary, Schiller proudly presents an algorithm which immediately and accurately localises coronary occlusions and provides early detection of STEMI. This algorithm is now integrated in the sophisticated touch ECG devices, the Cardovit MS line.
The 12-lead mobile ECG
CardioSecur, a personalised mobile 12-lead ECG system with four electrodes for iPhone and iPad, enables patients to monitor their symptoms and transmit the data to their physicians in less than a minute.
Partnership optimises uniform processes
By recognition and early intervention against the most significant risk factors, many heart diseases can be prevented.
Listen to your heart 24 hours a day
The ‘Fire of Life’ developed by Schiller is an intuitive visual presentation of frequency-domain heart rate variability (HRV) that makes the assessment of 24-hour results fast and simple.
Too many coronary stent procedures
In uncomplicated stable angina cases no evidence suggests that angioplasty reduces heart attacks or death risks, Mark Nicholls reports
3D targeting of the heart
The heart is a structure in three dimensions and today we see it in three dimensions,’ Jose Luis Zamorano Gomez MD declared with satisfaction.
Hardly unnecessary blood tests
Researchers at Johns Hopkins Bayview Medical Center used two relatively simple tactics to significantly reduce the number of unnecessary blood tests to assess symptoms of heart attack and chest pain and to achieve a large decrease in patient charges.
Disappointing HTN-3 trial results challenge future of procedure
It was the quiet before the storm. At the end of March, during the American College of Cardiology (ACC) meeting in Washington, the future of renal denervation was about to be decided with the presentation of the Medtronic-funded Simplicity HTN-3 clinical trial.
Pumping synchronously with the heart
Synchronised Cardiac Assist i-cor, which the company reports to be the first system that links mechanical circulatory support to the heartbeat.
First pacemaker with event-triggered IEGM transmissions
Biotronik, a leading manufacturer of cardiovascular medical technology, announced CE approval for its new Eluna pacemaker series. The new generation of pacemakers includes single and dual-chamber as well as cardiac resynchronization (CRT-P) devices.
Renal denervation on razor's edge ahead of trial results
It is the quiet before the storm. At the end of March, the future of renal denevation will be decided with the presentation of the Simplicity HTN-3 clinical trial at the American College of Cardiology meeting in Washington.
Promising substitutes for human hearts
Fully implantable mechanical hearts bring hope to 121,000 heart failure patients who will never receive a heart transplant
European approval for advanced SAPIEN 3 Valve
Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, announced that it has received CE Mark in Europe and is initiating the launch of its most advanced transcatheter aortic valve, the Edwards SAPIEN 3 valve.
New AF classification by ECG will deliver personalised treatment
Despite the availability of cardioversion, ablation and medications to treat AF, outcomes are often poor because it is unclear which patients will benefit most. A new classification of atrial fibrillation (AF) by electrocardiogram (ECG) is set to be developed by European experts to aid personalised management of this devastating condition.
Characterising plaques with millimetre-waves
The Plaque-CharM project funded by the German Federal Ministry of Education and Research is to develop novel sensor technology that can characterise arterial tissue in the smallest space – the tip of a catheter.
